Multisite Detection of Tn


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
24 01 2023
Historique:
pubmed: 22 12 2022
medline: 27 1 2023
entrez: 21 12 2022
Statut: ppublish

Résumé

In the United States,

Identifiants

pubmed: 36541772
doi: 10.1128/aac.01284-22
pmc: PMC9872605
doi:

Substances chimiques

Bacterial Proteins 0
Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0128422

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI152999
Pays : United States
Organisme : NIAID NIH HHS
ID : R00 AI072961
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI141349
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI134637
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI055449
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI121296
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI148593
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148342
Pays : United States

Références

BMC Genomics. 2013 Sep 01;14:595
pubmed: 24004955
Access Microbiol. 2021 Mar 22;3(3):000214
pubmed: 34151166
Genome Announc. 2016 Jun 23;4(3):
pubmed: 27340066
Infect Control Hosp Epidemiol. 2020 Jan;41(1):1-18
pubmed: 31767041
J Mol Microbiol Biotechnol. 2015;25(2-3):73-8
pubmed: 26159069
Nucleic Acids Res. 2002 Feb 15;30(4):866-75
pubmed: 11842097
Drug Resist Updat. 2020 Dec;53:100732
pubmed: 33189998
Eur J Clin Microbiol Infect Dis. 2018 May;37(5):927-936
pubmed: 29442195
J Antimicrob Chemother. 2018 Dec 1;73(12):3268-3278
pubmed: 30189014
J Antimicrob Chemother. 2002 Aug;50(2):253-6
pubmed: 12161407
Open Forum Infect Dis. 2021 Dec 23;9(3):ofab616
pubmed: 35155713
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S54-S62
pubmed: 30895215
PLoS One. 2007 Jul 04;2(7):e582
pubmed: 17611618
Microbiology (Reading). 2000 Jun;146 ( Pt 6):1481-1489
pubmed: 10846226
mBio. 2013 Aug 13;4(4):
pubmed: 23943759

Auteurs

Shelby R Simar (SR)

Center for Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA.

Truc T Tran (TT)

Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.

Kirsten B Rydell (KB)

Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.

Diana Panesso (D)

Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.
Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.

German A Contreras (GA)

Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.

Jose M Munita (JM)

Genomics and Resistant Microbes (GeRM) Group, Facultad de Medicina Clínica Alemana de Santiago, Universidad del Desarrollo, Santiago, Chile.
Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Santiago, Chile.

Renzo O Cifuentes (RO)

Jackson Health System, Miami Transplant Institute, Miami, Florida, USA.

Lilian M Abbo (LM)

Jackson Health System, Miami Transplant Institute, Miami, Florida, USA.

Pranoti Sahasrabhojane (P)

Department of Infectious Diseases, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

An Q Dinh (AQ)

Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.

Dierdre B Axell-House (DB)

Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.

Tor Savidge (T)

Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas, USA.

Samuel A Shelburne (SA)

Department of Infectious Diseases, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Blake M Hanson (BM)

Center for Infectious Diseases, University of Texas Health Science Center, School of Public Health, Houston, Texas, USA.

Cesar A Arias (CA)

Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.
Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH